Dianthus Therapeutics (DNTH) Depreciation and Depletion (2022 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Depreciation and Depletion of $27000.0 for Q3 2025, up 8.0% year-over-year from $25000.0 in Q3 2024, and down 10.0% quarter-over-quarter from $30000.0 in Q2 2025.
Dianthus Therapeutics (DNTH) Depreciation and Depletion (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Depreciation and Depletion history runs 4 years deep, the most recent figure standing at $27000.0 for Q3 2025.
- In Q3 2025, Depreciation and Depletion rose 8.0% year-over-year to $27000.0; the TTM figure through Sep 2025 stood at $110000.0 (up 22.22% YoY), while the FY2024 annual figure was $96000.0, up 43.28% from the prior year.
- Depreciation and Depletion for Q3 2025 stood at $27000.0, down from $30000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $30000.0 in Q2 2025, with the low at $6000.0 in Q3 2022.
- The 4-year median for Depreciation and Depletion is $22000.0 (2024), against an average of $20384.6.
- The sharpest annual moves came in 2023 and 2025: Depreciation and Depletion surged 216.67% in 2023, then rose 8.0% in 2025.
- Dianthus Therapeutics' Depreciation and Depletion stood at $11000.0 in 2022, then jumped by 81.82% to $20000.0 in 2023, then increased by 30.0% to $26000.0 in 2024, then advanced by 3.85% to $27000.0 in 2025.
- Business Quant data shows DNTH's Depreciation and Depletion at $27000.0 in Q3 2025, $30000.0 in Q2 2025, and $27000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 15,000.00 |